Zsuzsanna Szokol

Title: Zsuzsanna Szokol: Innovator in Pharmaceutical Development

Introduction

Zsuzsanna Szokol is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystals for drug formulation. With a total of 2 patents, his work focuses on innovative solutions for treating neurodegenerative and neurodevelopmental diseases.

Latest Patents

His latest patents include the development of Blarcamesine co-crystals for the manufacture of pharmaceutical dosage forms. These patents detail the ZnCl co-crystals of racemic-(±)-blarcamesine hydrochloride, as well as the (S)-(−)- and (R)-(+)-blarcamesine hydrochloride variants. The processes for preparation and pharmaceutical applications of these co-crystals aim to provide methods for treating conditions such as Alzheimer's disease, Parkinson's disease dementia, and Rett syndrome.

Career Highlights

Zsuzsanna Szokol is associated with Egis Gyogyszergyar Zrt., a leading pharmaceutical company in Hungary. His work at Egis has been instrumental in advancing pharmaceutical formulations and improving treatment options for patients with complex neurological conditions.

Collaborations

He collaborates with notable colleagues, including Tamás Nagy and András Balázs Dancsó, who contribute to the innovative research and development efforts within the company.

Conclusion

Zsuzsanna Szokol's contributions to pharmaceutical innovation highlight the importance of research in developing effective treatments for challenging diseases. His work continues to impact the field positively, paving the way for future advancements in medicine.